Hearne Michael S bought AUPH

May 18, 2026 · Form 4 insider transaction

Hearne Michael S bought 116,144 shares of Aurinia Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
116,144
Price
$0.00
Total value
N/A
Role
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 18, 2026
Filing dateMay 20, 2026
Shares owned after116,144
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Each performance stock unit ("PSU") represents a contingent right to receive one common share of the Issuer. 46,820 PSUs vest in four tranches upon the Issuer's common shares achieving four progressively higher target prices, with respective one year retention periods per tranche achievement. 69,324 PSUs vest in two tranches at the three and five year anniversary date of grant if the Issuer's common shares achieve target prices that represent significant increases from the share price on date of grant before the respective vesting date.

View the original Form 4 on SEC EDGAR